Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve U.S. Pivotal Trial

January 25, 2012 By AxoGen, Inc.

MINNEAPOLIS–(BUSINESS WIRE)–Medtronic, Inc. today announced it has completed patient enrollment in the extreme risk
study in its CoreValve U.S. Pivotal Trial. The company also received approval
from the U.S. Food and Drug Administration (FDA) for an extended investigation (under
the FDAs Continued Access Policy) to continue enrolling extreme risk patients
under a Continued Access Study protocol. In the Trials second study
evaluating high risk patients for aortic valve surgery, enrollment completion
is anticipated later this year.

The CoreValve U.S. Trial is evaluating the self-expanding
CoreValve System in three sizes (26mm, 29mm and 31mm) and using three delivery
access routes: through the transfemoral artery in the upper leg, through the
subclavian artery beneath the collar bone, and directly through the aorta via a
commonly-used, minimally invasive surgical incision that does not penetrate the
hearts ventricular wall.

“The CoreValve Trial investigators are very encouraged by
our experience using the investigative CoreValve system to treat patients with
severe aortic stenosis, and we are eager to fulfill the requirements of the
Trial in hopes of offering the valve to more patients in the future,” said
David H. Adams, M.D., chair of the Department of Cardiothoracic Surgery at The
Mount Sinai Medical Center and national co-principal investigator of the
CoreValve U.S. clinical trial. “With its varying sizes and vascular access
routes, the CoreValve System provides flexibility that we hope will accommodate
most patients anatomical circumstances.”

Overall, the trial is enrolling more than 1,500 patients in
45 U.S.
clinical sites, with approximately two-thirds of patients in the high risk
study. Patients in the extreme risk study are being evaluated against a
performance goal derived from contemporary studies. Patients in the high risk
group are being randomized one-to-one to either transcatheter aortic valve
implantation with the CoreValve System, or to surgical aortic valve
replacement.

“Medtronic is very pleased with our investigators
enrollment progress and with the clinical communitys enthusiasm for the
CoreValve U.S. Trial,” said John Liddicoat, M.D., senior vice president,
Medtronic, and president of the Medtronic Structural Heart Business.

The CoreValve System is designed to replace diseased aortic
valves without open-heart surgery. Worldwide, approximately 300,000 people have
been diagnosed with this condition, and approximately one-third of these
patients are deemed at too high a risk for open-heart surgery1. Since 2007, the
Medtronic CoreValve System has been implanted in more than 25,000 people in
more than 50 countries outside the U.S.

Additional information about the U.S. trial is available on www.clinicaltrials.gov and www.aorticstenosistrial.com.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical
technology – alleviating pain, restoring health, and extending life for
millions of people around the world.

1 Decision-making in elderly patients with severe aortic
stenosis: why are so many denied surgery? Bernard Iung et al. Eur Heart
J (December 2005) 26(24): 2714-2720.

Posted by Sean Fenske, Editor-in-Chief, MDT

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe